ArticleP & T : a peer-reviewed journal for formulary management2018

Poly (ADP-ribose) Polymerase Inhibitors in the Management of Ovarian Cancer: A Drug Class Review.

J Tanner Ringley et al.PubMed ↗Full text ↗

No numbers read from the abstract.